Moderna Stock News

The Qraft AI-Enhanced US Large Cap Momentum ETF (NYSE: AMOM ), an exchange-traded fund driven by artificial intelligence, has acquired new stakes in Tesla Inc. (NASDAQ: TSLA ), Netflix Inc. (NASDAQ: NFLX ) and Autodesk Inc. (NASDAQ: ADSK ), while entirely divesting its holdings in Intel Corp. (NASDAQ: INTC ), PayPal Holdings Inc . (NASDAQ: PYPL ) and Moderna Inc. (NASDAQ: MRNA ). What Happened : The ETFs latest portfolio after rebalancing in early December showed that it has also entirely divested its holdings in technology company International Business Machines Corp. (NYSE: IBM ) and oil giant ConocoPhillips (NYSE: COP ). The ETF, which has assets under management of $27.07 million, has a history of accurately predicting the price movements of Teslas shares. The fund now has electric vehicle maker Full story available on Benzinga.com

Moderna, Inc. (NASDAQ:MRNA) with the stream of -5.57% also noticed, India Energy Transfer LP (NYSE:ET) encountered a rapid change of -1.05% in the last hour of Fridays trading session. Moderna, The post Technical Snapshots for Investors: Moderna, Inc. (NASDAQ:MRNA), Energy Transfer LP (NYSE:ET) appeared first on Stocks Equity .

''For official requirements, it''s still two shots of the mRNA (Pfizer or Moderna) and one shot of the J&J for the official determination of what''s required or not,'' Fauci told ABC News on Sunday.

Railway Pension Investments Ltd acquired a new stake in shares of Moderna, Inc. (NASDAQ:MRNA) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 15,900 shares of the companys stock, valued at approximately $6,119,000. Other institutional investors and hedge funds also recently bought []

BOOSTER jabs are being made available for every eligible Brit over the age of 18 in the hope they will curb the rapid rise of Omicron infections in the UK. How effective are booster jabs against Omicron? Read more here Daily Express :: Health Feed Is the booster effective against Omicron? Pfizer, AstraZeneca, Moderna latest insight

Australians will now be able to receive a Moderna or a Pfizer booster shot five months after their last vaccination after new evidence showing immunity to the Omicron variant waning six months after a second dose.

Australia is cutting the standard waiting time for a booster shot to five months from six, following the first two doses

Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less effective the vaccine is. According to the same data gleaned from the blood plasma taken from 12 patients who tested positive for omicron, the team found that a two-shot course of Pfizer''s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, though it can thwart severe disease, according to laboratory experiments in South Africa, according to Bloomberg. The data comes courtesy of a team of researchers at the Africa Health Research Institute in Durban. Though data has been pouring out about omicron, and sometimes individual studies reach opposing findings, the general consensus is that omicron will be able to more easily evade protection afforded from the first generation of vaccines - however, the scientists say that people will still be protected against severe disease and death.

Australians now have a choice of booster shots after a major change to the nations vaccine program.

Taiwan Investigating Whether Mice Can Transmit Covid To Humans After Bitten Lab Employee Tests Positive As if the Covid hysteria being pushed by the media needed any more fodder for the flame, Taiwan is now in the process of investigating whether or not a bite by a mouse in a laboratory may have transmitted Covid to an employee. The incident involves a woman who worked at Academia Sinica, Taiwans top research institute, according to RT . She was diagnosed with Covid last month after health authorities confirmed she had been bitten twice by mice carrying the virus. While it is technically still unknown whether the virus came from the bite, RT notes that the countrys health minister, Chen Shih-chung said the: "possibility of infection from the workplace is higher because we have zero confirmed infections in the community. The employee had been vaccinated with Moderna''s vaccine and also had a record of great bio-security, the report says. About 100 people were in close contact with her - they are now in quarantine.

First Quadrant L P CA bought a new position in shares of Moderna, Inc. (NASDAQ:MRNA) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 3,017 shares of the companys stock, valued at approximately $1,161,000. A number of other institutional investors and hedge funds have also made changes []

Convergence Investment Partners LLC boosted its position in Moderna, Inc. (NASDAQ:MRNA) by 10.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,502 shares of the companys stock after purchasing an additional 136 shares during the quarter. Convergence Investment Partners LLCs holdings in Moderna were []

Rockland Trust Co. raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA) by 48.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,786 shares of the companys stock after buying an additional 585 shares during the quarter. Rockland Trust Co.s []